| Financial Year |
March 31 2023 |
| Monetary Funds |
540,548,088.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
58,756,874.47 |
| Accounts Receivable |
109,635,035.25 |
| Advances to Suppliers |
190,994,091.60 |
| Other Receivables |
30,607,549.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
545,231,459.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,984,287.09 |
| Total Current Assets |
1,633,216,134.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
16,927,862.34 |
| Long-term Equity Investment |
117,072,501.87 |
| Investment Properties |
-- |
| Fixed Assetes |
997,250,097.68 |
| Under-construction Projects |
1,003,721,553.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
817,010,969.33 |
| R&D expenses |
-- |
| Goodwill |
68,364,503.92 |
| Long-Term Deferred and Prepaid Expenses |
48,190,288.50 |
| Deferred Income Tax Assets |
96,128,949.32 |
| Other Non-Current Assets |
52,734,334.91 |
| Sub-Total of Non-Current Assets |
3,265,007,437.81 |
| Total Assets |
4,898,223,571.86 |
| Short-Term Loans |
1,126,775,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
201,810,000.00 |
| Accounts Payable |
294,260,974.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,181,916.35 |
| Taxes Payable |
24,570,635.52 |
| Interest Payable |
524,282.20 |
| Dividend Payable |
-- |
| Other payables |
66,290,297.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,000,000.00 |
| Other Current Liabilities |
56,542,222.10 |
| Sub-Total of Current Liabilities |
2,185,240,829.18 |
| Long-term Loans |
232,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
150,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,297,088.70 |
| Deferred Income Tax Liabilities |
1,607,457.84 |
| Other Non-Current Liabilities |
30,000.00 |
| Sub-Total of Non-Current Liabilities |
438,552,828.04 |
| Total Liabilities |
2,623,793,657.22 |
| Paid-In Capital(Or Share Stock) |
889,862,627.00 |
| Capital Surplus |
510,659,425.89 |
| Surplus Reserve |
116,633,028.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
749,258,610.21 |
| Minority Stockholder's Interest |
8,324,264.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,266,105,649.93 |
| Owner's Equity（Stockholder's Equity） |
2,274,429,914.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,898,223,571.86 |
